COMPARATIVE STUDY OF IMPRINT CYTOLOGY AND HISTOPATHOLOGY IN DIFFERENTIATING BENIGN AND MALIGNANT TUMOURS OF THE BREAST IN A TERTIARY CARE HOSPITAL

Main Article Content

Dr. Bargavi B
Dr. Pavithra R
Dr. Prakashiny
Dr. Jesu Magdalene
Dr. Ragashree V

Keywords

Imprint cytology; breast neoplasm; diagnostic accuracy; sensitivity.

Abstract

Introduction:

Globally, breast cancer is the most common cancer among women; however, it is also a significant growing burden on the health systems of developing countries. Histopathology remains the gold standard for diagnosing all malignancies, including breast cancers. However, it is not a useful intraoperative diagnostic tool. Imprint cytology is a rapid as well as an inexpensive way to obtain a definitive diagnosis using minimal laboratory facilities. This study will compare the diagnostic accuracy of imprint cytology to histopathology in determining whether breast tumours are benign or malignant.


Materials and Methods:

This study was a hospital-based prospective comparative study performed at the Department of Pathology, ACS Medical College and Hospital, Chennai, India over a period of twelve months (May 2025 – April 2026). A total of thirty surgically excised breast specimens that met the study's entry criteria were enrolled in this study. The histopathological diagnoses were used as the gold standard to determine the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), overall diagnostic accuracy, and kappa coefficient of imprint cytology.


Results:

For the thirty specimens, there were a total of nineteen benign (benign breast disease) specimens and eleven malignant (untreated breast cancer) specimens. Imprint cytology had a sensitivity of 90.9%, a specificity of 100.0%, a PPV of 100.0%, an NPV of 95.0% and an overall diagnostic accuracy of 96.7%. The kappa value (0.91) indicates that there was nearly perfect agreement between the two methods.


Conclusion:

Imprint cytology had excellent accuracy in distinguishing benign from malignant breast tumours. Invasive lobular carcinoma was the most difficult diagnosis to make. It was concluded that imprint cytology should be routinely used as an adjunct to histopathology to make intraoperative diagnoses, especially where cryostat facilities are unavailable.


 

Abstract 0 | Pdf Downloads 0

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
2. Malvia S, Bagadi SA, Dubey US, Saxena S. Epidemiology of breast cancer in Indian women. Asia Pac J Clin Oncol. 2017;13(4):289–295.
3. National Cancer Registry Programme, Indian Council of Medical Research. Three-year report of population based cancer registries: 2012–2014. Bengaluru: NCDIR-NCRP; 2016.
4. Buzdar AU. Preoperative chemotherapy treatment of breast cancer — a review. Cancer. 2007;110(11):2394–2407.
5. Scolyer RA, Murali R, McCarthy SW, Thompson JF. Pathologic examination of sentinel lymph nodes from melanoma patients. Semin DiagnPathol. 2008;25(2):100–111.
6. Dey P. Frozen section of breast: a critical review. J Cytol. 2011;28(4):175–179.
7. Gupta RK. Value of imprint smears in the intraoperative diagnosis of tumours and tumor-like lesions. DiagnCytopathol. 1991;7(6):584–588.
8. Sharma N, Sharma M. Correlation between imprint cytology and the histopathology of breast lesions. Indian J Pathol Res Pract. 2019;8(5):538–543.
9. Mahadevappa A, Nisha TG, Manjunath GV. Intra-operative diagnosis of breast lesions by imprint cytology and frozen section with histopathological correlation. J Clin Diagn Res. 2012;6(7):1183–1187.
10. Devojee M, Akarsh MP, Kishore N. Touch imprint cytology in correlation with histopathology in breast lesions. MedPulse Int J Pathol. 2018;7(1):01–05.
11. Ramraje SN, Bharambe BM, Tote VD. Imprint smear cytology and histopathology of breast lesions: a comparative evaluation with review of literature. Indian J Pathol Microbiol. 2013;56(3):225–230.
12. Sauer T, Karesen R, Utsunomiya N, Naess O, Kjellevold KH. Touch preparation cytology from core-cut needle biopsies of breast lesions. Acta Cytol. 1998;42(3):733–736.
13. Klimstra DS, Heffess CS, Oertel JE, Rosai J. Acinar cell carcinoma of the pancreas: a clinicopathologic study of 28 cases. Am J SurgPathol. 1992;16(9):815–837.
14. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, editors. WHO Classification of Tumours of the Breast. 4th ed. Lyon: IARC Press; 2012.
15. Koss LG, Melamed MR. Koss' Diagnostic Cytology and Its Histopathologic Bases. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006.
16. Indian Council of Medical Research. Consensus document for management of breast cancer. New Delhi: ICMR; 2016.

Most read articles by the same author(s)